Clinical Trials Browser

Phase 2/3 × Unknown × Ado-Trastuzumab Emtansine × Clear all

NCT04924699 2023-03-17

A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer

Phase 2/3 Unknown

Breast Neoplasms